InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Scopelianos Angelo, Directeur de la R&D. Officer active across 1 company, notably Axogen, Inc.. Aggregated, 12 reports have been recorded. Activity tracked since 19 July 2021. The latest transaction was disclosed on 16 March 2024 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Declarations12 total
21,281 shares0Common StockSEC:0000805928-24-000047:0
2,571 shares0Common StockSEC:0000805928-23-000138:0
8,250 shares0Common StockSEC:0000805928-23-000024:0
1,150 shares0Common StockSEC:0000805928-22-000137:0
2,571 shares0Common StockSEC:0000805928-22-000094:0
11,000 shares0Common StockSEC:0000805928-22-000034:0
1,325 shares0Common StockSEC:0000805928-22-000013:0
1,325 shares0Common StockSEC:0000805928-22-000013
1,150 shares0Common StockSEC:0000805928-21-000184
1,150 shares0Common StockSEC:0000805928-21-000184:0
2,572 shares0Common StockSEC:0000805928-21-000144
2,572 shares0Common StockSEC:0000805928-21-000144:0
12 of 12 declarations
About Scopelianos Angelo
Scopelianos Angelo is Chief R&D Officer at Axogen, Inc. In this role, he is responsible for research and development of new products and technologies. His expertise in innovation and product development enables him to contribute to enhancing the solutions offered by the company. Angelo is committed to supporting Axogen's mission of improving patient outcomes.
